ataxia telangiectasia
-
Ataxia-telangiectasia: A review of movement disorders, clinical features and genotype correlations - Addendum.
-
Ataxia-telangiectasia: A review of movement disorders, clinical features, and genotype correlations.
-
Ataxia-telangiectasia: Immunodeficiency and survival.
-
Ataxia-telangiectasia: recommendations for multidisciplinary treatment.
-
Ataxia-telangiectasia.
-
ATM and the molecular pathogenesis of ataxia telangiectasia.
-
Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.
-
ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T.
-
Audiological findings in children with ataxia-telangiectasia (A-T) syndrome.
-
B-cell subsets imbalance and reduced expression of CD40 in ataxia-telangiectasia patients.
-
Brain edema with clasmatodendrosis complicating ataxia telangiectasia.
-
Cerebral abnormalities in adults with ataxia-telangiectasia.
-
Childhood colon cancer in a patient with ataxia telangiectasia.
-
Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM.
-
Cognitive phenotype in ataxia-telangiectasia.
-
Comparison of major lymphocyte subpopulations and recent thymic emigrants in patients with ataxia telangiectasia and age-matched healthy groups.
-
Consequences of the delayed diagnosis of ataxia-telangiectasia.
-
Corynebacterium propinquum bronchopneumonia in a child with ataxia telangiectasia.
-
Cough ability measurements and recurrent respiratory symptoms in individuals with Ataxia Telangiectasia.
-
Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response.